Literature DB >> 23596266

The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei, Taiwan: experience at a teaching hospital.

Jui Wang1, Wei-Hsiu Chiu2, Ran-Chou Chen3, Fu-Li Chen1, Tao-Hsin Tung4.   

Abstract

The authors sought to explore the prevalence and factors related to nonalcoholic fatty liver disease (NAFLD) among occupational population in Taipei, Taiwan. A total of 8347 healthy adults voluntarily admitted to annual physical check-up. Blood samples and ultrasound-proved fatty liver sonography results were collected. The results showed that the prevalence of NAFLD was 48.4% and revealed a statistically significant increase with increasing population age. Males exhibited a greater prevalence of NAFLD than did females (57.8% vs 32.4%, P < .001). Using multiple logistic regression analysis, in addition to male gender, older age, higher body mass index, higher aspartate aminotransferase level, higher alanine aminotransferase level, presence of hypertension, presence of hyperuricemia, presence of hypercholesterolemia, higher fasting plasma glucose, and presence of hypertriglyceridemia were the significant factors associated with NAFLD. The differences in occupational professions were revealed. In conclusion, occupational populations are asymptomatic, and the diagnosis of NAFLD should be considered with older age, hyperuricemia, higher aspartate aminotransferase level, higher alanine aminotransferase level, and metabolic risk factors.
© 2013 APJPH.

Entities:  

Keywords:  nonalcoholic fatty liver disease; occupational population; prevalence

Mesh:

Substances:

Year:  2013        PMID: 23596266     DOI: 10.1177/1010539513483830

Source DB:  PubMed          Journal:  Asia Pac J Public Health        ISSN: 1010-5395            Impact factor:   1.399


  7 in total

1.  Sex influenced association of directly measured insulin sensitivity and serum transaminase levels: Why alanine aminotransferase only predicts cardiovascular risk in men?

Authors:  Barbara Buday; Peter Ferenc Pach; Botond Literati-Nagy; Marta Vitai; Gyorgyi Kovacs; Zsuzsa Vecsei; Laszlo Koranyi; Csaba Lengyel
Journal:  Cardiovasc Diabetol       Date:  2015-05-20       Impact factor: 9.951

Review 2.  Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: A systematic review and meta-analysis.

Authors:  Shunquan Wu; Fuquan Wu; Yingying Ding; Jun Hou; Jingfeng Bi; Zheng Zhang
Journal:  Sci Rep       Date:  2016-09-16       Impact factor: 4.379

3.  Heat Shock Protein 60 Restricts Release of Mitochondrial dsRNA to Suppress Hepatic Inflammation and Ameliorate Non-Alcoholic Fatty Liver Disease in Mice.

Authors:  Ying-Hsien Huang; Feng-Sheng Wang; Pei-Wen Wang; Hung-Yu Lin; Sheng-Dean Luo; Ya-Ling Yang
Journal:  Int J Mol Sci       Date:  2022-01-05       Impact factor: 5.923

4.  Gender-specific prevalence of metabolic-associated fatty liver disease among government employees in Tianjin, China: a cross-sectional study.

Authors:  Ya-Ping Huang; Shi Zhang; Minying Zhang; Yi Wang; Wen-Hong Wang; Jing Li; Chunjun Li; Jing-Na Lin
Journal:  BMJ Open       Date:  2021-12-15       Impact factor: 2.692

5.  Severity of Nonalcoholic Fatty Liver Disease is Associated With Cardiovascular Outcomes in Patients With Prehypertension or Hypertension: A Community-Based Cohort Study.

Authors:  Qi-Rui Song; Shuo-Lin Liu; Qian-Hui Ling; Qian-Nan Gao; Rui-Xue Yang; Shuo-Hua Chen; Shou-Ling Wu; Mu-Lei Chen; Jun Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-25       Impact factor: 6.055

6.  Dietary pulp from Fructus Schisandra Chinensis supplementation reduces serum/hepatic lipid and hepatic glucose levels in mice fed a normal or high cholesterol/bile salt diet.

Authors:  Nan Sun; Si-Yuan Pan; Yi Zhang; Xiao-Yan Wang; Pei-Li Zhu; Zhu-Sheng Chu; Zhi-Ling Yu; Shu-Feng Zhou; Kam-Ming Ko
Journal:  Lipids Health Dis       Date:  2014-03-12       Impact factor: 3.876

7.  High-Content Screening of a Taiwanese Indigenous Plant Extract Library Identifies Syzygium simile leaf Extract as an Inhibitor of Fatty Acid Uptake.

Authors:  Chia-Hung Yen; Hsun-Shuo Chang; Tsai-Hsun Yang; Sheng-Fan Wang; Ho-Cheng Wu; Yu-Chang Chen; Kai-Jay Lin; Sheena Wang
Journal:  Int J Mol Sci       Date:  2018-07-22       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.